Kazuhito Hirata

Kazuhito Hirata

Auto-generated profile, based on publicly available information

Kazuhito Hirata

Division of Cardiology, Okinawa Chubu Hospital, Japan

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2010 in Journal of Cardiology
Verified
Journal Article
Closed access
PDF file
KHKazuhito Hirata
Kazuhito Hirata
MWMinoru Wake
Minoru Wake
MKMasahiro Kyushima
Masahiro Kyushima
TTTakanori Takahashi
Takanori Takahashi
JNJun Nakazato
Jun Nakazato
HAHiroaki Asato
Hiroaki Asato

11 November 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KHKazuhito Hirata
Kazuhito Hirata
MWMinoru Wake
Minoru Wake
TTTakanori Takahashi
Takanori Takahashi
JNJun Nakazato
Jun Nakazato
NYNobuhito Yagi
Nobuhito Yagi
YYYutaka Yamaguchi
Yutaka Yamaguchi
Initial diagnosis of acute aortic dissection (AAD) in the emergency room (ER) is sometimes difficult or delayed. The aim of this study is to define clinical predictors related to inappropriate or delayed diagnosis of Stanford type A AAD. We conducted a retrospective analysis of 127 consecutive patients with type A AAD who presented to the ER within 12 h of symptom onset (age: 69.0 ± 15.4 years, male/female = 49/78). An inappropriate initial diagnosis (IID) was considered if AAD was not included in the differential diagnosis or if chest computed tomography or echocardiography was not performed as initial imaging tests. Clinical variables were compared between IID and appropriate diagnosis group. The time to final diagnosis (TFD) was also evaluated. Delayed diagnosis (DD) was defined as TFD > third quartile. Clinical factors predicting DD were evaluated in comparison with early diagnosis (defined as TFD within the third quartile). In addition, TFD was compared with respect to each clinical variable using a rank sum test. An IID was determined for 37% of patients. Walk-in (WI) visit to the ER [odds ratio (OR) 2.6, 95% confidence interval (CI) = 1.01–6.72, P = 0.048] and coronary malperfusion (CM, OR = 6.48, 95% CI = 1.14–36.82, P = 0.035) were predictors for IID. Overall, the median TFD was 1.5 h (first/third quartiles = 0.5/4.0 h). DD (>4.5 h) was observed in 27 cases (21.3%). TFD was significantly longer in WI patients (median and first/third quartiles = 1.0 and 0.5/2.85 h for the ambulance group vs. 3.0 and 1.0/8.0 h for the WI group, respectively; P = 0.003). Multivariate analysis revealed that WI visit was the only predictor for DD (OR = 3.72, 95% CI = 1.39–9.9, P = 0.009). TFD was significantly shorter for appropriate diagnoses than for IIDs (1.0 vs. 6.0 h, respectively; P < 0.0001). WI visit to the ER and CM were predictors for IID, and WI was the only predictor for DD in acute type A AAD in the community hospital.

13 July 2019 in European Heart Journal - Case Reports
Verified
Journal Article
Open access
PDF file
KHKazuhito Hirata
Kazuhito Hirata
TTToshiho Tengan
Toshiho Tengan
MWMinoru Wake
Minoru Wake
TTTakanori Takahashi
Takanori Takahashi
TIToru Ishimine
Toru Ishimine
HMHidemitsu Mototake
Hidemitsu Mototake
Background: Bioprosthetic tricuspid valve stenosis is a late sequela of tricuspid valve replacement (TVR); however, detailed information regarding its clinical picture is lacking. Case summary: Thirty-one patients with bioprosthetic TVR (mean age: 60.5 ± 16.6 years, male/female: 11/20) were followed-up for 79.5 ± 49.1 months (14–188 months). Eleven patients developed bioprosthetic tricuspid valve stenosis (mean tricuspid gradient >5 mmHg) at a median interval of 96 months (interquartile range: 61–114 months). The mean tricuspid gradient at the time of tricuspid valve stenosis diagnosis was 10.9 ± 3.9 mmHg. Although the mid-term tricuspid valve stenosis-free survival was favourable (92.4% at 60 and 78.7% at 84 months), it had declined steeply to 31.5% by 120 months. Ten out of 11 tricuspid valve stenosis patients showed signs of right heart failure (RHF) as manifested by oedema and elevated jugular venous pressure, requiring moderate-to-high doses of diuretics. Diastolic rumble was audible in 10 patients. Five of the 11 tricuspid valve stenosis patients required redo TVR as a result of refractory RHF. Examination of the five excised bioprostheses showed pannus in four, fusion of the commissure in three, native valve attachment in two, and sclerosis in one. Detailed clinical pictures and pathology of the explanted valves in three cases that underwent surgery are presented in this case series. Discussion: Bioprosthetic tricuspid valve stenosis is not uncommon after 8 years. Tricuspid valve replacement performed at the second surgery was associated with a higher incidence of bioprosthetic tricuspid valve stenosis.

Verified
Journal Article
Open access
PDF file
RSRyota Sato
Ryota Sato
KSKenji Sakamoto
Kenji Sakamoto
KKKoichi Kaikita
Koichi Kaikita
KTKenichi Tsujita
Kenichi Tsujita
KNKoichi Nakao
Koichi Nakao
MIMasaharu Ishihara
Masaharu Ishihara
While prognoses in relation to myocardial infarction (MI) type have been elucidated in past reports, the results were not consistent, perhaps due to occurrence of Type 2 MI with CVS and its mortality. The Japanese registry of acute Myocardial Infarction diagnosed by Universal Definition (J-MINUET) is a prospective multicenter registry in Japan. In contrast to thromboembolic event-related Type 1 myocardial infarction (MI), clinical features of Type 2 MI, including coronary vasospasm (CVS), are varied due to the heterogeneous nature of its development. To elucidate the MI type-related all-cause mortality, 2989 consecutive patients with AMI were stratified as Type 1 MI, Type 2 MI with CVS, and Type 2 MI with non-CVS. Most patients (n = 2834; 94.8%) were classified as Type 1 MI and 155 patients (5.2%) were classified as Type 2 MI. Of the Type 2 MI patients, 87 (56% of Type 2 MI) were diagnosed as MI with CVS. Although the 3-year mortality was comparable between Type 1 and Type 2 MI patients, significant differences were observed between Type 2 MI with CVS and with non-CVS (3.4% and 22.1%, p < 0.001). Among Japanese patients with AMI, mortality rates between Type 1 MI and Type 2 MI are comparable, but further stratification of Type 2 MI (with or without CVS) may be useful in predicting the prognosis of patients with Type 2 MI.

24 February 2012
Verified
Book Chapter
Open access
KHKazuhito Hirata
Kazuhito Hirata
THTomoya Hiratsuji
Tomoya Hiratsuji
MWMinoru Wake
Minoru Wake
HMHidemitsu Mototake
Hidemitsu Mototake

26 January 2016 in Circulation
Verified
Journal Article
Open access
PDF file
KHKazuhito Hirata
Kazuhito Hirata
NYNobuhito Yagi
Nobuhito Yagi
SKShuji Kubota
Shuji Kubota
MWMinoru Wake
Minoru Wake
TTToshiho Tengan
Toshiho Tengan